InvestorsHub Logo
Followers 617
Posts 27445
Boards Moderated 3
Alias Born 11/16/2007

Re: Ebuilder post# 89213

Sunday, 01/25/2015 10:51:11 PM

Sunday, January 25, 2015 10:51:11 PM

Post# of 403529
Btw, this part is actually correct since he was at Dana Farber at the time. ... Harvard. It's just the resume floating around that is incorrect in some places. Go to the Cellceutix site for the correct one.

http://www.thehindu.com/todays-paper/tp-national/tp-kerala/ifcr-india/article241265.ece

Headed by noted Cancer drug discoverer from Harward University of USA, Dr Krishna Menon and his team of researchers from Boston based Kard Scientific Labs and Cellceutix Inc, IFCR India has already rolled out 18 batches of Clinical Research professionals into the CR Industry. Many of IFCR India Scholars are well positioned in the management and research cadre of Multinational Pharma/ Biotech companies like Johnson & Johnson, Pfizer, Dr Reddys, Accenture, Novartis, GlaxoSmithKline, Novo nordisk, Sanofi Aventis, Quintiles etc. With cent percentage placement track record into MNCs, IFCR India is now poised to offer UGC approved programs in Clinical Research and Regulatory Affairs for the first time in the state of Kerala, through its MBA (Health Care) & MSc (Clinical Research) program to be launched in August-2009



And, I believe Cellceutix is still working with researchers from this program.

Good night all... I'm off to bed.







To follow KarinCA, click here then click "Follow This Member" under my photo.

Be kinder than necessary, for everyone you meet is fighting some kind of battle.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News